TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva. July 13, 2007
TCL Archive In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks July 30, 1982
TCL Archive In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2 April 28, 1978
